The top 15 spots on this list are fully occupied by European and American companies, forming an unshakable industry barrier. Among them,Abbott topped the global list with $44.33 billion in medical device revenue, followed closely by Medtronic and Johnson & Johnson with $34.76 billion and $34 billion, respectively, securing their positions in the top three globally.From the list data,The top ten companies all achieved revenues exceeding 19 billion USD, with Abbott, Medtronic, and Johnson & Johnson surpassing 30 billion USD.`, demonstrating absolute scale advantages.`

TOP15 LIST

In the TOP10 lineup, the track distribution exhibits diverse characteristics.: Comprehensive healthcare giants such as Abbott and Johnson & Johnson occupy a dominant position with their full industrial chain layout, specialized companies like Medtronic, Stryker, and Danaher continue to lead in niche markets, while the three major imaging powerhouses—Siemens Healthineers, GE Healthcare, and Philips—firmly control the high-end medical imaging market.

Moreover, Boston Scientific, Baxter, Alcon, and Intuitive Surgical ranked 11th to 14th respectively, each with revenues exceeding 10 billion US dollars, forming the second tier of the global medical device industry.

From the perspective of the industry landscape, the core competitiveness of European and American companies is reflected in three dimensions: first,Technical Barriers, holding core patents in advanced imaging, minimally invasive surgery, life sciences and other fields, forming a technical monopoly; followed byGlobal Channels, which has established a global sales network and after-sales service system through decades of market layout; finallyM&A Integration, continuously acquiring leading enterprises in niche markets to improve the product portfolio and consolidate market position.

In addition, among the top 20 companies on the list,Only two Japanese companies, Terumo and Olympus, made the list, with the rest being European and American companies, highlighting the absolute dominance of Europe and America in the global medical device industry.

Surrounded by global giants, China's medical device companies have shown strong growth momentum.A total of eight companies, including Mindray, United Imaging, Xinhua, Yuwell, MicroPort, Lepu, Sisram, and Dahbo, have successfully made it to the 2025 Global Top 100 Medical Device Companies list.

Mindray ranked 24th globally with $4.6 billion in revenue, being the only Chinese enterprise breaking into the top 25, and firmly holding the leading position as a China-produced medical device manufacturer.As a benchmark in China's medical device industry, Mindray Medical is making comprehensive efforts in three core sectors: life information and support, in vitro diagnostics, and medical imaging. Its products are available in over 190 countries and regions worldwide. In fields such as patient monitors and ultrasound diagnostic equipment, Mindray has achieved domestic substitution for international giants, becoming an undeniable Chinese force in the global medical device market.

United Imaging Healthcare ranked 47th with a revenue of $1.72 billion, becoming a representative enterprise of China-produced high-end medical imaging.United Imaging Healthcare has broken the long-term monopoly of foreign companies in high-end imaging equipment fields such as CT and MRI. Its independently developed products, such as 3.0T Magnetic Resonance and PET-CT, have reached international advanced levels. These products have not only been widely used in tertiary hospitals in China but have also successfully entered the global mainstream market, promoting Chinese-produced high-end imaging equipment to the world.

Apart from the two leading companies, Mindray and United Imaging,Xinhua Medical(57 individuals, 1.32 billion USD),Yuwell Medical(60 persons, 1.12 billion USD),Minimally Invasive Medical(62 individuals, 1.01 billion USD),Lepu Medical(70 people, 870 million USD),Sisram Medical(99 persons, 346 million USD),Dabo Medical(100 companies, $344 million) also successfully made it to the top 100, coveringMultiple segments, including integrated equipment, home medical devices, cardiovascular interventions, medical aesthetics, and orthopedics, demonstrate the growth vitality of China's entire medical device industry chain.

Yuwell Medical as the leader in home medical devices，In oxygen generators, ventilators, and sphygmomanometers...and other product fields dominate the Chinese market, with products exported globally, becoming a benchmark for Chinese-made home medical devices entering the world.Minimally Invasive Medical and Lepu Medical Achieve Continuous Breakthroughs in the Cardiovascular Intervention FieldProducts such as stents and pacemakers have achieved domestic substitution in China, breaking the monopoly of foreign enterprises;Dabo Medical has been deeply engaged in the field of orthopedic implants for many years., the product performance has reached the international advanced level, becoming a representative of domestically produced orthopedic devices in China;Sisram Medical Ltd Emerges as a Rising Force in the Medical Aesthetics Device Sector, becoming the leading enterprise in the overseas market for domestically produced medical aesthetic devices.

Despite Chinese companies achieving multiple breakthroughs in the global top 100, there is still a significant scale gap compared to European and American giants. The list showsAccording to the data, Philips, ranked 10th globally, achieved a revenue of $19.7 billion, which is more than four times that of the leading company in China. Advanced core technologies and global market share remain critical bottlenecks for domestically produced enterprises to overcome.

Currently, the global medical device industry is at a critical period of technological transformation and market restructuring, and Chinese enterprises are facing unprecedented development opportunities.On the one hand, the continuous expansion of domestic demand driven by China's new medical infrastructure and the intensifying aging population provides vast growth opportunities for domestic companies; on the other hand, these companies’ ongoing investment in technology research and development has led to continuous breakthroughs in areas such as advanced imaging, minimally invasive surgery, and life sciences, gradually breaking foreign monopolies.

At the same time, the policy dividend continues to be released, and the National Medical Products Administration (NMPA) keeps optimizing the medical device approval process, encouraging the R&D of innovative medical devices, providing strong support for technological innovation by domestically produced enterprises. In addition, the "Belt and Road" initiative is driving the accelerated overseas expansion of domestically produced medical devices, with more and more Chinese companies bringing their products to the global market, enhancing international influence.

Industry experts said,This list fully demonstrates the development achievements of China's medical device industry, and the entry of eight enterprises into the top 100 is an important symbol of the rise of domestically produced devices.In the future, as Chinese enterprises continue to make efforts in core technologies, global channels, and brand building, they are expected to occupy a more important position in the global medical device market, achieving a leap from "Made in China" to "Created in China." In this regard, DeviceHome will continue to pay attention.

Attachment: Top 100 Global Medical Device Companies in 2026